Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $6.8750.

Several research analysts have commented on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Sensus Healthcare in a research note on Tuesday, April 21st. Maxim Group cut their target price on shares of Sensus Healthcare from $8.00 to $6.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Alliance Global Partners assumed coverage on shares of Sensus Healthcare in a report on Friday, March 6th. They issued a “buy” rating and a $7.50 target price on the stock. Wall Street Zen cut shares of Sensus Healthcare from a “sell” rating to a “strong sell” rating in a report on Saturday, May 9th. Finally, Citigroup restated a “buy” rating on shares of Sensus Healthcare in a report on Friday, May 8th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in SRTS. Greenline Wealth Management LLC bought a new position in shares of Sensus Healthcare in the fourth quarter worth approximately $513,000. Divisadero Street Capital Management LP grew its holdings in shares of Sensus Healthcare by 39.5% in the third quarter. Divisadero Street Capital Management LP now owns 452,897 shares of the company’s stock worth $1,422,000 after purchasing an additional 128,224 shares during the last quarter. Rothschild Wealth LLC bought a new position in shares of Sensus Healthcare in the fourth quarter worth approximately $500,000. North Star Investment Management Corp. bought a new position in shares of Sensus Healthcare in the first quarter worth approximately $500,000. Finally, Pacific Ridge Capital Partners LLC grew its holdings in shares of Sensus Healthcare by 21.8% in the fourth quarter. Pacific Ridge Capital Partners LLC now owns 698,634 shares of the company’s stock worth $2,781,000 after purchasing an additional 125,245 shares during the last quarter. Institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Stock Performance

SRTS stock opened at $2.71 on Wednesday. The company has a market capitalization of $44.61 million, a PE ratio of -5.77 and a beta of 1.09. Sensus Healthcare has a one year low of $2.66 and a one year high of $5.92. The company’s 50 day moving average price is $3.62 and its two-hundred day moving average price is $4.04.

Sensus Healthcare (NASDAQ:SRTS) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.04). The business had revenue of $3.39 million for the quarter, compared to analysts’ expectations of $5.32 million. Sensus Healthcare had a negative return on equity of 15.79% and a negative net margin of 34.50%.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.

The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.